Exploring the opportunities and challenges of direct-to-consumer medical testing
Join the Centre for Personalised Medicine (CPM), University of Oxford for a day-long symposium exploring the evolving landscape of direct-to-consumer (DTC) medical testing. Bringing together academic experts, clinicians, industry innovators, and regulatory professionals, this event will delve into the opportunities and challenges of DTC testing across hormone health and fertility, and genetics, and its broader impact on patients and the NHS. The day will feature presentations and panel discussions, examining how these technologies are influencing, and may continue to shape, patient pathways, clinical practices, and patient-clinician relationships within healthcare. The programme will also engage with the ethical, philosophical, and regulatory implications of DTC medical testing, asking critical questions about evidence, oversight, and responsibility in a rapidly changing health consumer market and its impacts on the NHS. With contributions from thought leaders across medicine, ethics, philosophy, regulation, and industry, this event provides a timely platform for interdisciplinary dialogue on a topical issue in modern healthcare.
This event will be structured around three key themes:
- Innovations in direct-to-consumer medical testing
- Implications of direct-to-consumer medical testing for clinical practice and patient pathways
- Ethical, philosophical, and regulatory considerations of direct-to-consumer medical testing
Registration details will be available in due course.